Similar articles

• [Extended spectrum beta lactamase forming pathogens (ESBL)].

  Gastmeier P. Gastmeier P. Med Klin Intensivmed Notfmed. 2012 Nov;107(8):592-3. doi: 10.1007/s00063-012-0185-z. Med Klin Intensivmed Notfmed. 2012. PMID: 23138656 German. No abstract available.
• Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.

  Arnold HM, Hollands JM, Skrupky LP, Smith JR, Juang PH, Hampton NB, McCormick S, Reichley RM, Hoban A, Hoffmann J, Micek ST, Kollef MH. Arnold HM, et al. Ann Pharmacother. 2013 Feb;47(2):170-80. doi: 10.1345/aph.1R523. Epub 2013 Jan 22. Ann Pharmacother. 2013. PMID: 23341160 Clinical Trial.
• Gram-negative sepsis in the intensive care unit: avoiding therapeutic failure.

  Chapman S Jr, Iredell JR. Chapman S Jr, et al. Curr Opin Infect Dis. 2008 Dec;21(6):604-9. doi: 10.1097/QCO.0b013e328319ea67. Curr Opin Infect Dis. 2008. PMID: 18978528 Review.
• Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.

  Johnson MT, Reichley R, Hoppe-Bauer J, Dunne WM, Micek S, Kollef M. Johnson MT, et al. Crit Care Med. 2011 Aug;39(8):1859-65. doi: 10.1097/CCM.0b013e31821b85f4. Crit Care Med. 2011. PMID: 21499086
• [Tarragona strategy--appropriate antibiotic therapy in the ICU].

  Engelmann L, Schmitt DV. Engelmann L, et al. Med Klin Intensivmed Notfmed. 2014 Apr;109(3):156-61. doi: 10.1007/s00063-013-0310-7. Epub 2014 Mar 22. Med Klin Intensivmed Notfmed. 2014. PMID: 24652507 Review. German.